Form 4: Outset Medical Director Kevin O'Boyle Receives Stock Units

Director Kevin O'Boyle of Outset Medical, Inc. was granted 15,135 Restricted Stock Units (RSUs) on May 14, 2025, which vest quarterly over three years.

Summary

• On May 14, 2025, Kevin O'Boyle, a director of Outset Medical, Inc., received 15,135 Restricted Stock Units (RSUs).
• Each RSU represents the right to receive one share of Outset Medical common stock.
• The RSUs will vest quarterly over a three-year period, contingent upon O'Boyle's continued service with the company.

Sentiment

Score: 6

Explanation: The document is a standard SEC Form 4 filing, indicating a routine grant of stock units. It's neutral in tone and doesn't suggest any significant positive or negative developments for the company.

Positives

• The grant of RSUs to a director aligns their interests with those of the shareholders, incentivizing them to work towards the company's long-term success.

Future Outlook

The RSUs will vest quarterly over three years, subject to the reporting person's continued service through the applicable vesting date.

Industry Context

Stock grants are a common form of executive compensation in the medical device industry, used to attract and retain talent and align their interests with shareholders.

Comparison to Industry Standards

• Stock grants to directors are a standard practice across publicly traded companies, including those in the medical device sector.
• The vesting schedule of three years is also typical for such grants, aligning with long-term performance goals.

Stakeholder Impact

• The grant of RSUs to a director can have a positive impact on shareholders by aligning management's interests with theirs.

Key Dates

Keywords

Restricted Stock Units, RSUs, Director, Kevin O'Boyle, Outset Medical, OM, Stock Options, Vesting